Recently, a genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer reported that genetically determined expression level of RPRD1B was associated with cisplatin-induced peripheral neuropathy [73]. The gene discussed is RPRD1B; the disease is peripheral neuropathy.